Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polycythemia Vera (PV)”

113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 113 results

Not applicableStudy completedNCT00038675
What this trial is testing

Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myeloid LeukemiaPolycythemia Vera+2 more
M.D. Anderson Cancer Center 125
Not applicableLooking for participantsNCT06743035
What this trial is testing

Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly

Who this might be right for
Polycythemia Vera
iOMEDICO AG 200
Testing effectiveness (Phase 2)Study completedNCT02515630
What this trial is testing

Momelotinib in Transfusion-Dependent Adults With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)

Who this might be right for
Primary Myelofibrosis (PMF)Post-polycythemia Vera (Post-PV) MyelofibrosisPostessential Thrombocythemia (Post-ET) Myelofibrosis
Sierra Oncology LLC - a GSK company 41
Large-scale testing (Phase 3)Study completedNCT03952039
What this trial is testing

An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib

Who this might be right for
Primary MyelofibrosisPost-Polycythemia VeraMyelofibrosis
Celgene 202
Not applicableStudy completedNCT00433862
What this trial is testing

Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders

Who this might be right for
Polycythemia VeraEssential ThrombocytosisIdiopathic Myelofibrosis+2 more
National Institutes of Health Clinical Center (CC) 8
Large-scale testing (Phase 3)Ended earlyNCT01645124
What this trial is testing

Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV)

Who this might be right for
Polycythemia Vera
Consorzio Mario Negri Sud 365
Large-scale testing (Phase 3)Looking for participantsNCT04655092
What this trial is testing

Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients

Who this might be right for
Polycythemia Vera (PV)
PharmaEssentia Japan K.K. 67
Not applicableUnknownNCT02809274
What this trial is testing

Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features

Who this might be right for
Polycythemia Vera
Rambam Health Care Campus 200
Testing effectiveness (Phase 2)Study completedNCT04182100
What this trial is testing

Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply

Who this might be right for
Polycythemia Vera (PV)
PharmaEssentia Japan K.K. 29
Testing effectiveness (Phase 2)Study completedNCT00946270
What this trial is testing

Pomalidomide for Myelofibrosis Patients

Who this might be right for
Polycythemia VeraThrombocythemia
M.D. Anderson Cancer Center 70
Testing effectiveness (Phase 2)Study completedNCT01236638
What this trial is testing

Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)

Who this might be right for
Primary MyelofibrosisPost-Polycythemia Vera MyelofibrosisPost-Essential Thrombocythemia Myelofibrosis
Sierra Oncology LLC - a GSK company 120
Testing effectiveness (Phase 2)Study completedNCT01149681
What this trial is testing

Clinical Trial of Aplidin® in Patients With Primary Myelofibrosis

Who this might be right for
Myelofibrosis
PharmaMar 12
Not applicableNot Yet RecruitingNCT07445893
What this trial is testing

A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV

Who this might be right for
Polycythemia Vera (PV)
Duan Minghui 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05481151
What this trial is testing

Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV

Who this might be right for
Polycythemia Vera
PharmaEssentia 111
Testing effectiveness (Phase 2)Looking for participantsNCT06985147
What this trial is testing

A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

Who this might be right for
Polycythemia Vera (PV)
Disc Medicine, Inc 60
Large-scale testing (Phase 3)Study completedNCT02101268
What this trial is testing

Efficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MF

Who this might be right for
Primary Myelofibrosis (PMF)Post-polycythemia Vera (Post-PV)Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
Sierra Oncology LLC - a GSK company 156
Not applicableNot Yet RecruitingNCT06785870
What this trial is testing

EVAluation of Erythrocytosis PRospEctive Cohort STudy

Who this might be right for
ErythrocytosisPolycythemiaPolycythemia Secondary+5 more
Cyrus Hsia 1,500
Testing effectiveness (Phase 2)Study completedNCT02098161
What this trial is testing

LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis

Who this might be right for
Polycythemia Vera, Post-Polycythemic Myelofibrosis PhasePrimary MyelofibrosisSecondary Myelofibrosis
M.D. Anderson Cancer Center 50
Large-scale testing (Phase 3)Active Not RecruitingNCT04717414
What this trial is testing

An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions

Who this might be right for
Myeloproliferative DisordersMyelofibrosisPrimary Myelofibrosis+2 more
Celgene 313
Post-approval studies (Phase 4)Not Yet RecruitingNCT06290765
What this trial is testing

Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera

Who this might be right for
Polycythemia VeraMyeloproliferative Neoplasm
PharmaEssentia 70
Load More Results